source
- Experts warn of safety risks as FDA targets compounded GLP-1 weight-loss drugs sold by telehealth firmsAt the HLTH conference, experts highlighted growing concerns about telehealth companies that sell compounded GLP-1 weight-loss medications. These firms create custom formulations and ship them dir…
- Novo accelerates consumer focus with Wegovy pill launch and upcoming CagriSema, as marketing chief Ed Cinca returnsNovo is intensifying its consumer‑focused strategy, highlighted by the Wegovy oral pill and the forthcoming CagriSema product. The effort coincides with the return of senior vice president of mark…